Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.

Best practice & research. Clinical haematology - 1 Jan 2000

Falini Brunangelo, Martelli Maria Paola

Abstract excerpt

Acute myeloid leukemia (AML) is a clinically and molecularly heterogeneous disease. Cytogenetics and FISH have contributed to the stratification of AML patients into favorable, intermediate, and unfavorable risk categories. However, until recently, the prognostic stratification and treatment decision for the intermediate risk category, mostly comprising AML patients with normal cytogenetics (CN-AML), has been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytogenetic Analysis
Share to DNA (Cytosine-5-)-Methyltransferases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Methyltransferase 3A

Share to fms-Like Tyrosine Kinase 3

Share to Neoplasm, Residual

Share to Nucleophosmin

Share to Patient Selection

Share to Terminology as Topic

Source

Identifiers

PMID: 26590764
DOI: 10.1016/j.beha.2015.10.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.PMID 26590764Read ↗

Mutational landscape of AML with normal cytogenetics: biological and clinical implications.Semantic proximity Read ↗

Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.Semantic proximity Read ↗

Molecular pathogenesis of acute myeloid leukemia: a diverse disease with new perspectives.Semantic proximity Read ↗

Cytogenetics and genomics of acute myeloid leukemia.Semantic proximity Read ↗

A concise review on the molecular genetics of acute myeloid leukemia.Semantic proximity Read ↗

Updates in molecular genetics of acute myeloid leukemia.Semantic proximity Read ↗

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

The Mutational Landscape of Acute Myeloid Leukemia and Its Impact.Semantic proximity Read ↗

Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid LeukemiaSemantic proximity Read ↗

Acute myeloid leukaemia genomics.Semantic proximity Read ↗

Prognostically important molecular markers in cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.